The global blood plasma market is witnessing robust expansion, driven by the increasing demand for plasma-derived therapies, rising prevalence of chronic diseases, and advancements in biopharmaceutical technologies. Plasma, the liquid component of blood, plays a crucial role in treating conditions such as hemophilia, immune deficiencies, and neurological disorders. With continuous innovation in...